These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 4452544)

  • 1. Untractable hypoglycemia in an infant: studies on pancreas insulin and glucagon.
    Rancon F; Laburthe M; Rosselin G; Freychet P
    Horm Metab Res; 1974 Nov; 6(6):443-7. PubMed ID: 4452544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adenylate cyclase system of the liver].
    Hanoune J
    Biol Gastroenterol (Paris); 1976; 9(1):33-52. PubMed ID: 183838
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the administration of glucagon and insulin antibodies to rats.
    Barling P; Beloff-Chain A
    Horm Metab Res; 1973 May; 5(3):154-9. PubMed ID: 4714540
    [No Abstract]   [Full Text] [Related]  

  • 5. Mobile receptor and collision coupling mechanisms for the activation of adenylate cyclase by glucagon.
    Houslay MD
    Adv Cyclic Nucleotide Res; 1981; 14():111-9. PubMed ID: 6269373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and partial characterization of crystalline insulin and the proinsulin-containing b-component from human pancreas].
    Kohnert KD; Zühlke H; Ziegler M; Schmidt S
    Acta Biol Med Ger; 1973; 31(4):515-23. PubMed ID: 4781900
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon and adenylate cyclase: binding studies and requirements for activation.
    Levey GS; Fletcher MA; Klein I
    Adv Cyclic Nucleotide Res; 1975; 5():53-65. PubMed ID: 165684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA; Jan SH; Datta A
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of glucagon sensitivity in neonatal rat liver.
    Vinicor F; Higdon G; Clark JF; Clark CM
    J Clin Invest; 1976 Sep; 58(3):571-8. PubMed ID: 956386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of halothane on rat liver adenylate cyclase: role of cytosol components.
    Bernstein KJ; Verosky M; Triner L
    Anesth Analg; 1985 May; 64(5):531-7. PubMed ID: 3994014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of insulin and glucagon. Heterogeneity and characterization of insulin and glucagon degrading enzyme systems in cell fractions of the rat liver].
    Ansorge S; Kaiser B; Senger U; Bohley P; Langner J; Kirschke H
    Acta Biol Med Ger; 1972; 28(5):761-77. PubMed ID: 4627491
    [No Abstract]   [Full Text] [Related]  

  • 12. The HLB dependency for detergent solubilization of hormonally sensitive adenylate cyclase.
    Storm DR; Field SO; Ryan J
    J Supramol Struct; 1976; 4(2):221-31. PubMed ID: 1263511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of pancreatic glucagon secretion by glucose.
    Ohneda A; Aguilar-Parada E; Eisentraut AM; Unger RH
    Diabetes; 1969 Jan; 18(1):1-10. PubMed ID: 5761864
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the autonomic nervous system in the control of glucagon release during insulin hypoglycaemia in the calf.
    Vaughan NJ; Bloom SR; Ogawa O; Bircham PM; Edwards AV
    Experientia; 1973; 29(7):805-6. PubMed ID: 4724704
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut glucagon and reactive hypoglycaemia.
    Bloom S
    Lancet; 1973 Jan; 1(7796):202. PubMed ID: 4118814
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of polypeptide hormones by enzymatic degradation.
    Knights EB; Baylin SB; Foster GV
    Lancet; 1973 Sep; 2(7831):719-23. PubMed ID: 4125803
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.
    Kahn CR; Neville DM; Roth J
    J Biol Chem; 1973 Jan; 248(1):244-50. PubMed ID: 4348209
    [No Abstract]   [Full Text] [Related]  

  • 18. The defect in insulin receptors in obese-hyperglycemic mice: a probable accompaniment of more generalized alterations in membrane glycoproteins.
    Chang KJ; Huang D; Cuatrecasas P
    Biochem Biophys Res Commun; 1975 May; 64(2):566-73. PubMed ID: 167751
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin and glucagon degradation by the same enzyme.
    Duckworth WC; Kitabchi AE
    Diabetes; 1974 Jun; 23(6):536-43. PubMed ID: 4834293
    [No Abstract]   [Full Text] [Related]  

  • 20. Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon".
    Müller TD; Habegger K
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.